Celldex Therapeutics, Inc.;University of Iowa Research Foundation
发明人:
申请号：
EP11825951.4
公开号：
EP2616092B1
申请日:
2011.09.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).
